Kura Oncology Inc (KURA)
22.98
+1.11
(+5.08%)
USD |
NASDAQ |
May 16, 16:00
23.00
+0.02
(+0.07%)
Pre-Market: 20:00
Kura Oncology Market Cap: 1.751B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.751B |
| May 15, 2024 | 1.666B |
| May 14, 2024 | 1.593B |
| May 13, 2024 | 1.570B |
| May 10, 2024 | 1.578B |
| May 09, 2024 | 1.582B |
| May 08, 2024 | 1.565B |
| May 07, 2024 | 1.605B |
| May 06, 2024 | 1.601B |
| May 03, 2024 | 1.572B |
| May 02, 2024 | 1.569B |
| May 01, 2024 | 1.545B |
| April 30, 2024 | 1.495B |
| April 29, 2024 | 1.528B |
| April 26, 2024 | 1.497B |
| April 25, 2024 | 1.447B |
| April 24, 2024 | 1.428B |
| April 23, 2024 | 1.427B |
| April 22, 2024 | 1.386B |
| April 19, 2024 | 1.335B |
| April 18, 2024 | 1.347B |
| April 17, 2024 | 1.370B |
| April 16, 2024 | 1.416B |
| April 15, 2024 | 1.448B |
| April 12, 2024 | 1.484B |
| Date | Value |
|---|---|
| April 11, 2024 | 1.554B |
| April 10, 2024 | 1.516B |
| April 09, 2024 | 1.575B |
| April 08, 2024 | 1.556B |
| April 05, 2024 | 1.551B |
| April 04, 2024 | 1.551B |
| April 03, 2024 | 1.550B |
| April 02, 2024 | 1.563B |
| April 01, 2024 | 1.662B |
| March 28, 2024 | 1.624B |
| March 27, 2024 | 1.612B |
| March 26, 2024 | 1.555B |
| March 25, 2024 | 1.598B |
| March 22, 2024 | 1.629B |
| March 21, 2024 | 1.626B |
| March 20, 2024 | 1.670B |
| March 19, 2024 | 1.651B |
| March 18, 2024 | 1.602B |
| March 15, 2024 | 1.701B |
| March 14, 2024 | 1.673B |
| March 13, 2024 | 1.738B |
| March 12, 2024 | 1.699B |
| March 11, 2024 | 1.737B |
| March 08, 2024 | 1.792B |
| March 07, 2024 | 1.695B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
293.01M
Minimum
Mar 18 2020
2.748B
Maximum
Dec 11 2020
1.091B
Average
950.89M
Median
Jun 10 2020
Market Cap Benchmarks
| AIM ImmunoTech Inc | 19.46M |
| Perspective Therapeutics Inc | 897.98M |
| Protalix BioTherapeutics Inc | 85.78M |
| Electromed Inc | 147.67M |
| Armata Pharmaceuticals Inc | 95.81M |
Market Cap Related Metrics
| Price to Book Value | 3.466 |
| Price | 22.98 |
| Earnings Yield | -9.44% |